A cross-disciplinary science environment between chemistry, engineering and clinical sciences would allow a holistic approach for researchers to address long-range challenges in Human health (better diagnostics, better disease control, better prevention). Until ChEM-H at Stanford University no such institution has been founded. The institute focuses on molecules, allowing researchers to study human biology at a more fundamental level than cells, thereby paving the way for new tools to cure or prevent disease. Above all, ChEM-H educates a new type of student who will transform healthcare – someone with the eyes of a clinician, the wisdom of a scientist, and the problem solving skills of an engineer. The jury thought that Carolyn Bertozzi’s institute truly represents the need for novel, interdisciplinary applied research to identify new ways to better public health.
Login or Register
You need to be logged in to use this feature.
United States
Carolyn Bertozzi
Stanford University
Prof. Carolyn Bertozzi is the Anne T. and Robert M. Bass Professor of Chemistry at Stanford University, Investigator of the Howard Hughes Medical Institute, and Baker Family Director of Stanford ChEM-H (Chemistry, Engineering, and Medicine for Human Health). Prof. Bertozzi is known for developing innovative technologies that have opened new avenues for biological discovery and therapeutic development. Several of her inventions have been translated to commercial settings. In 2022, Prof. Carolyn Bertozzi was awarded with the Nobel Prize in Chemistry for the development of click chemistry and bioorthogonal chemistry.
Explore more content of Falling Walls
Further Activities to have a look at